Siemens Healthineers Captures FDA Clearance for Bedside Head CT
U.S. Food & Drug Administration grants 510(k) clearance for SOMATOM On.site.
Siemens Healthineers announced Wednesday it has secured 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its mobile head CT scanner SOMATOM On.site.
The system is designed to provide head imaging for critically patients without needing to transport them outside of the intensive care unit. Doing so eliminates both the risk and the cost of moving a patient to the radiology department, company officials said.
“The SOMATOM On.site transforms the delivery of care for critically ill patients who require a CT head scan,” said Douglas Ryan, vice president of computed tomography at Siemens Healthineers North America. “Bedside imaging helps to reduce patient transports, thereby reducing the risk of infection while improving workforce efficiency.”
According to company information, SOMATOM On.site can provide consistent patient positioning in the scanner through easy scan set-up, fast workflow, and integrated patient support accessories. The user interface – myExam Companion – assists the technologist with system navigation to ensure consistent results, and an integrated camera allows for easy maneuvering with real-time viewing on the built-in Touch UI display.
In addition, company officials said, the scanners telescopic gantry enables the technologist to move the radiation source away from the patient during scanning while the rest of the machine stays in place. And, based on company data, the telescopic, self-shielded gantry design with attachable front and back radiation shields reduces scatter radiation and provides radiation protection for neighboring patients and staff.
CT Perfusion Study Shows Enhanced Detection of Medium Vessel Occlusions with Emerging AI Software
May 21st 2025The Rapid CTP AI software offered 23 percent greater detection of medium vessel occlusions in comparison to the Viz CTP AI software, according to research presented at the European Stroke (Organization) Conference (ESOC).
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
